Italy Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Italy Pharmaceuticals and Healthcare Report Q3 2013 Jun 5th 2013, 00:00, by rnrmahesh Executive Summary BMI View: The ongoing hospital debt situation, in addition to the Italian government’s focus on dereimbursement, will offset any benefits of the recently passed legislation that encourages increased hospital provision of innovative medicines. Headline Expenditure Projections ? Pharmaceuticals: EUR23.53bn (US$30.25bn) in 2012 to EUR22.58bn (US$30.25bn) in 2013; 4.0% in local currency terms. ? Healthcare: EUR154.20bn (US$198.25bn) in 2012 to EUR156.83bn (US$210.15bn) in 2013; +1.7% growth in local currency terms. Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99924. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/italy-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions